HMG CoA reductase inhibitors
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
FLUVASTATIN SODIUM: products 1 to 5 of 5.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Lescol 20mg CapDIN 02061562 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Lescol 40mg CapDIN 02061570 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Lescol XL 80mg ER TabDIN 02250527 | General benefit | $1.6225per source unit | Requirements & sourcesBuild cost plan |
| Teva-Fluvastatin 20mg CapDIN 02299224 | General benefit | $0.6882per source unit | Requirements & sourcesBuild cost plan |
| Teva-Fluvastatin 40mg CapDIN 02299232 | General benefit | $0.9671per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
Products assigned to this ATC category in the held Health Canada records. Combinations assigned to other categories are not included; search their ingredient or product name separately.
C10AA HMG CoA reductase inhibitors. Health Canada DPD extract 2026-09-02.
WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index, 2026-01-20
C10AA HMG CoA reductase inhibitors